Is AKYA or DIVO a better dividend investment in 2026?

AKYA currently yields 155.04% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: AKYA offers higher current income.

What is the dividend yield difference between AKYA and DIVO?

AKYA has a forward dividend yield of 155.04% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 148.55 percentage points.

Home › Compare › AKYA vs DIVO

AKYA vs DIVO: Dividend Comparison 2026

AKYA yields 155.04% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AKYA wins by $29.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AKYA

● Live price

155.04%

Share price

$1.29

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.59M

Annual income

$13,040,704.30

Full AKYA calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — AKYA vs DIVO

📍 AKYA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AKYA	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AKYA + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AKYA pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKYA

Annual income on $10K today (after 15% tax)

$13,178.29/yr

After 10yr DRIP, annual income (after tax)

$11,084,598.66/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, AKYA beats the other by $11,083,764.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKYA + DIVO for your $10,000?

AKYA: 50%DIVO: 50%

100% DIVO50/50100% AKYA

Portfolio after 10yr

$14.81M

Annual income

$6,520,842.99/yr

Blended yield

44.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AKYA right now

AKYA

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$4.98

+286.0% upside vs current

Range: $2.40 — $7.50

Altman Z

-4.2

Piotroski

4/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKYA buys

DIVO buys

No recent congressional trades found for AKYA or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAKYADIVO

Forward yield	155.04% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$29.59M	$30.7K ✓
Annual income after 10y	$13,040,704.30 ✓	$981.68
Total dividends collected	$27.44M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AKYA vs DIVO ($10,000, DRIP)

Year	AKYA Portfolio	AKYA Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$26,204	$15,503.88	$11,349	$649.42	+$14.9K → AKYA
2	$66,007	$37,968.38	$12,833	$688.83	+$53.2K → AKYA
3	$160,011	$89,383.96	$14,459	$727.90	+$145.6K → AKYA
4	$373,718	$202,506.35	$16,238	$766.49	+$357.5K → AKYA
5	$841,906	$442,027.47	$18,179	$804.47	+$823.7K → AKYA
6	$1,831,486	$930,646.81	$20,293	$841.71	+$1.81M → AKYA
7	$3,851,778	$1,892,087.52	$22,591	$878.14	+$3.83M → AKYA
8	$7,840,307	$3,718,904.61	$25,087	$913.65	+$7.82M → AKYA
9	$15,463,748	$7,074,619.86	$27,791	$948.18	+$15.44M → AKYA
10	$29,586,915	$13,040,704.30	$30,718	$981.68	+$29.56M → AKYA

AKYA vs DIVO: Complete Analysis 2026

AKYA — Stock

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Full AKYA Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this AKYA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKYA vs SCHD AKYA vs JEPI AKYA vs O AKYA vs KO AKYA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.